Photoacoustic Imaging and artificial intelligence-based theranostic approach for cancer
Unsolved Needs
Health programs crave for diagnostic imaging and eradication of chemoresistant neoplastic lesions smaller than 1 mm of size. PHIRE aims at bringing closer to market a novel high-resolution theranostic medical device effective in the clinical applications for lesions <1 mm, ready for application in human bladder cancer and effective both in male and female patients.
Start date/End date
01-09-2023 31-08-2026
EU Contribution
Coordinated By
OSPEDALE SAN RAFFAELE SRL
Lights the fire of undetectable bladder cancer lesions
The adoption of PHIRE solution
in relevant environment, by providing:
Gold nanorods
A large-scale synthesis of urine-stable gold nanords for clinical use.
The PHIRE consortium
The PHIRE consortium follows a multicultural and multidisciplinary approach (urology, radiology, biology, nanotechnology, chemistry and mathematical modelling), bringing together scientists with a proven track record of >400 manuscripts.
